Free press releases distribution network?

More news: Research
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



The Solution for Contract Research Organizations Market Information Needs - New analysis from Frost & Sullivan titled Global CRO Spending Trends provides detailed revenue forecasts for the CRO markets and key trends in R&D spending and clinical trials
The Solution for Contract Research Organizations Market Information Needs

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2007/10/15 - New analysis from Frost & Sullivan titled Global CRO Spending Trends provides detailed revenue forecasts for the CRO markets and key trends in R&D spending and clinical trials.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Contract Research Organizations (CROs) are emerging as the hotbed for driving innovation and efficiency for pharmaceutical and biotechnology companies and have moved beyond being an outsourcing option to becoming a necessary partner in the value chain. Pharmaceutical and biotechnology companies are continuously seeking to improve competitiveness by reducing costs and decreasing time to market of drugs while the regulatory environment continues to turn more rigorous. As the market continues to expand and inorganic growth emerges as a critical component of market expansion, the trend of continuing to focus more on core expertise rather than adding new services becomes crucial for CROs.

New analysis from Frost & Sullivan titled Global CRO Spending Trends provides detailed revenue forecasts for the CRO markets and key trends in R&D spending and clinical trials. The analysis is available through our CRO Growth Partnership program as well as our Pharmaceuticals & Biotechnology Subscription.

If you are interested in a virtual brochure, detailing this latest analysis, Global CRO Spending Trends, or Frost & Sullivan's subscription content, then send an email to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, email address, city, state, and country. Upon receipt, an overview will be sent to you by email, and we will then forward this information to our team who will contact you at the above information.

"CROs are increasingly looking at emerging markets as drivers of future growth. The percentage share of clinical trials conducted in North America is expected to undergo a marginal decline despite a healthy overall growth in volume of clinical trials." notes Frost & Sullivan Research Analyst, Barath Shankar. "This signifies the increasing penetration of CROs and also the emergence of emerging markets as hotspots for clinical trials and other areas of outsourcing services."

The CRO Growth Partnership program is a global content solution focused on the CRO sector. Global market coverage by region as well as end-user research provides both supply and demand side information to fulfill the market intelligence needs of companies interested in the contract research industry.

Frost & Sullivan's Pharmaceuticals & Biotechnology practice provides global industry analysis, consulting, customer/end-user and market research information to help our clients with their informational, growth and strategy needs. Subscription clients with Frost & Sullivan's CRO Growth Partnership program gain not only from in-depth research services covering the market, but from vital End-User research.

"Partnering with us enables companies interested in the CRO space to meet their growth and strategic objectives, and information needs," says Frost & Sullivan's North America Pharmaceuticals Industry Manager, Daniel Ruppar. "The ability for clients to have direct access to our global team of analysts as well as market and end user information in this space is something that sets us apart from the competition."

Frost & Sullivan's Pharmaceuticals and Biotechnology Group provides research in the following markets: oncology, cardiovascular, CNS, biotechnology, diabetes/metabolic disease, contract research and manufacturing, infectious disease, respiratory, generics, specialty pharmaceuticals and drug delivery. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.

Recent research service titles include: Global CRO Spending Trends, U.S. CRO Markets, Drug Delivery: Snapshots and Highlights, CRO – Competing in North America and APAC (End-user studies).

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


The Solution for Contract Research Organizations Market Information Needs

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Melina Trevino 
210.247.2440 melina.trevino[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Research Most Recent Related Press Releases:

Royal DSM to Make Equity Investment in Amyris with the Purpose of Establishing A Long-term Relationship
DSM Unveils New Beauty Active At NYSCC Suppliers’ Day
Iridea Bio - A New Sustainable Paint Made with DSM’s Decovery® Plant-based Resin
DSM to Showcase A Wide Range of Innovative Composite Solutions
DSM’s New Protective Delvo®Guard Cultures Reduce Food Waste in Dairy
DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids from Natural Marine Algae for Animal Nutrition
DSM Introduces Dyneema Purity® Black Fiber - The First Black Medical-grade UHMWPE Fiber
Research by German Wildau Technical University Confirms Long-term Performance of Dyneema® Soft Ballistics for Use in Bullet Resistant Vests
DSM Dyneema Wins Significant Patent Case in Israel
Actamax™ Submits IDE to FDA for Pivotal Study on Novel Sprayable Adhesion Barrier Device

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today